Cargando…
Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). Here, we augment the proteostasis network of Drosophila SCA3 models with Hsp104, a powerful protein disaggregase...
Autores principales: | Cushman-Nick, Mimi, Bonini, Nancy M., Shorter, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764203/ https://www.ncbi.nlm.nih.gov/pubmed/24039611 http://dx.doi.org/10.1371/journal.pgen.1003781 |
Ejemplares similares
-
MR Imaging of SCA3/MJD
por: Wan, Na, et al.
Publicado: (2020) -
Polyglutamine-expanded ataxin3 alter specific gene expressions through changing DNA methylation status in SCA3/MJD
por: Ding, Dongxue, et al.
Publicado: (2020) -
Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014) -
Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice
por: Long, Zhe, et al.
Publicado: (2018) -
The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD
por: de Oliveira, Camila Maria, et al.
Publicado: (2023)